LymphedemaV1, PascalFrancis, Curation, bibRecord, 000417

Use of the dermatology life quality index in filarial lymphoedema patients

Identifieur interne : 000417 ( PascalFrancis/Curation ); précédent : 000416; suivant : 000418

Use of the dermatology life quality index in filarial lymphoedema patients

Auteurs : B. V. Babu [Inde] ; A. N. Nayak [Inde] ; K. Rath [Inde] ; A. S. Kerketta [Inde]

Source :

Transactions of the Royal Society of Tropical Medicine and Hygiene [ 0035-9203 ] ; 2006.

RBID : Pascal:06-0124585

Descripteurs français

Pascal (Inist)
- Lymphoedème, Filariose lymphatique, Qualité vie, Dermatologie, Homme, Inde, Médecine tropicale.
Wicri :
- geographic : Inde.
- topic : Homme.

English descriptors

KwdEn :
- Dermatology, Human, India, Lymphatic filariasis, Lymphedema, Quality of life, Tropical medicine.

Abstract

The global programme to eliminate lymphatic filariasis has alleviation of suffering and disability as one of its components, and many efforts are being taken across the globe in this direction. However, there is no effective tool to assess the impact of these efforts on patients' quality of life and/or lessening of disability and suffering. The present paper reports the use of the Dermatology Life Quality Index (DLQI) in filarial lymphoedema patients. DLQI scores were collected from 203 patients recruited from a clinic and from the community. The DLQI score ranged from 0 to 17, and a mean score of 2.7 (SD 4.4) or 9.0% disability. This score is lower than many skin diseases reported so far. The scores for individual questions vary, but the degree of consistency of responses between questions is high. The differences between sexes, place of recruitment and grades of lymphoedema are not significant. Although the DLQI measures the quality of life due to lymphoedema, this study further warrants development of a good quality-of-life index for lymphoedema patients.

A01	`01`	`1`		`@0 0035-9203`
A02	`01`			`@0 TRSTAZ`
A03		`1`		`@0 Trans. r. soc. trop. med. hyg.`
A05				`@2 100`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Use of the dermatology life quality index in filarial lymphoedema patients`
A11	`01`	`1`		`@1 BABU (B. V.)`
A11	`02`	`1`		`@1 NAYAK (A. N.)`
A11	`03`	`1`		`@1 RATH (K.)`
A11	`04`	`1`		`@1 KERKETTA (A. S.)`
A14	`01`			`@1 Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post) @2 Bhubaneswar 751023 @3 IND @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A20				`@1 258-263`
A21				`@1 2006`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 3084 @5 354000135338080100`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 31 ref.`
A47	`01`	`1`		`@0 06-0124585`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Transactions of the Royal Society of Tropical Medicine and Hygiene`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 The global programme to eliminate lymphatic filariasis has alleviation of suffering and disability as one of its components, and many efforts are being taken across the globe in this direction. However, there is no effective tool to assess the impact of these efforts on patients' quality of life and/or lessening of disability and suffering. The present paper reports the use of the Dermatology Life Quality Index (DLQI) in filarial lymphoedema patients. DLQI scores were collected from 203 patients recruited from a clinic and from the community. The DLQI score ranged from 0 to 17, and a mean score of 2.7 (SD 4.4) or 9.0% disability. This score is lower than many skin diseases reported so far. The scores for individual questions vary, but the degree of consistency of responses between questions is high. The differences between sexes, place of recruitment and grades of lymphoedema are not significant. Although the DLQI measures the quality of life due to lymphoedema, this study further warrants development of a good quality-of-life index for lymphoedema patients.
C02	`01`	`X`		`@0 002B12B04`
C02	`02`	`X`		`@0 002B05E03B4D`
C03	`01`	`X`	`FRE`	`@0 Lymphoedème @5 01`
C03	`01`	`X`	`ENG`	`@0 Lymphedema @5 01`
C03	`01`	`X`	`SPA`	`@0 Linfedema @5 01`
C03	`02`	`X`	`FRE`	`@0 Filariose lymphatique @5 02`
C03	`02`	`X`	`ENG`	`@0 Lymphatic filariasis @5 02`
C03	`02`	`X`	`SPA`	`@0 Filariasis linfática @5 02`
C03	`03`	`X`	`FRE`	`@0 Qualité vie @5 10`
C03	`03`	`X`	`ENG`	`@0 Quality of life @5 10`
C03	`03`	`X`	`SPA`	`@0 Calidad vida @5 10`
C03	`04`	`X`	`FRE`	`@0 Dermatologie @5 11`
C03	`04`	`X`	`ENG`	`@0 Dermatology @5 11`
C03	`04`	`X`	`SPA`	`@0 Dermatología @5 11`
C03	`05`	`X`	`FRE`	`@0 Homme @5 12`
C03	`05`	`X`	`ENG`	`@0 Human @5 12`
C03	`05`	`X`	`SPA`	`@0 Hombre @5 12`
C03	`06`	`X`	`FRE`	`@0 Inde @2 NG @5 13`
C03	`06`	`X`	`ENG`	`@0 India @2 NG @5 13`
C03	`06`	`X`	`SPA`	`@0 India @2 NG @5 13`
C03	`07`	`X`	`FRE`	`@0 Médecine tropicale @5 14`
C03	`07`	`X`	`ENG`	`@0 Tropical medicine @5 14`
C03	`07`	`X`	`SPA`	`@0 Medicina tropical @5 14`
C07	`01`	`X`	`FRE`	`@0 Nématodose`
C07	`01`	`X`	`ENG`	`@0 Nematode disease`
C07	`01`	`X`	`SPA`	`@0 Nematodosis`
C07	`02`	`X`	`FRE`	`@0 Helminthiase`
C07	`02`	`X`	`ENG`	`@0 Helminthiasis`
C07	`02`	`X`	`SPA`	`@0 Helmintiasis`
C07	`03`	`X`	`FRE`	`@0 Parasitose`
C07	`03`	`X`	`ENG`	`@0 Parasitosis`
C07	`03`	`X`	`SPA`	`@0 Parasitosis`
C07	`04`	`X`	`FRE`	`@0 Infection`
C07	`04`	`X`	`ENG`	`@0 Infection`
C07	`04`	`X`	`SPA`	`@0 Infección`
C07	`05`	`X`	`FRE`	`@0 Asie @2 NG`
C07	`05`	`X`	`ENG`	`@0 Asia @2 NG`
C07	`05`	`X`	`SPA`	`@0 Asia @2 NG`
C07	`06`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 37`
C07	`06`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`06`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`07`	`X`	`FRE`	`@0 Lymphatique pathologie @5 38`
C07	`07`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 38`
C07	`07`	`X`	`SPA`	`@0 Linfático patología @5 38`
N21				`@1 072`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000543

Links to Exploration step

Pascal:06-0124585

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Use of the dermatology life quality index in filarial lymphoedema patients</title>
<author><name sortKey="Babu, B V" sort="Babu, B V" uniqKey="Babu B" first="B. V." last="Babu">B. V. Babu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Nayak, A N" sort="Nayak, A N" uniqKey="Nayak A" first="A. N." last="Nayak">A. N. Nayak</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Rath, K" sort="Rath, K" uniqKey="Rath K" first="K." last="Rath">K. Rath</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Kerketta, A S" sort="Kerketta, A S" uniqKey="Kerketta A" first="A. S." last="Kerketta">A. S. Kerketta</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0124585</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0124585 INIST</idno>
<idno type="RBID">Pascal:06-0124585</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000543</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000417</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Use of the dermatology life quality index in filarial lymphoedema patients</title>
<author><name sortKey="Babu, B V" sort="Babu, B V" uniqKey="Babu B" first="B. V." last="Babu">B. V. Babu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Nayak, A N" sort="Nayak, A N" uniqKey="Nayak A" first="A. N." last="Nayak">A. N. Nayak</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Rath, K" sort="Rath, K" uniqKey="Rath K" first="K." last="Rath">K. Rath</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Kerketta, A S" sort="Kerketta, A S" uniqKey="Kerketta A" first="A. S." last="Kerketta">A. S. Kerketta</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Transactions of the Royal Society of Tropical Medicine and Hygiene</title>
<title level="j" type="abbreviated">Trans. r. soc. trop. med. hyg.</title>
<idno type="ISSN">0035-9203</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Transactions of the Royal Society of Tropical Medicine and Hygiene</title>
<title level="j" type="abbreviated">Trans. r. soc. trop. med. hyg.</title>
<idno type="ISSN">0035-9203</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dermatology</term>
<term>Human</term>
<term>India</term>
<term>Lymphatic filariasis</term>
<term>Lymphedema</term>
<term>Quality of life</term>
<term>Tropical medicine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term>
<term>Filariose lymphatique</term>
<term>Qualité vie</term>
<term>Dermatologie</term>
<term>Homme</term>
<term>Inde</term>
<term>Médecine tropicale</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The global programme to eliminate lymphatic filariasis has alleviation of suffering and disability as one of its components, and many efforts are being taken across the globe in this direction. However, there is no effective tool to assess the impact of these efforts on patients' quality of life and/or lessening of disability and suffering. The present paper reports the use of the Dermatology Life Quality Index (DLQI) in filarial lymphoedema patients. DLQI scores were collected from 203 patients recruited from a clinic and from the community. The DLQI score ranged from 0 to 17, and a mean score of 2.7 (SD 4.4) or 9.0% disability. This score is lower than many skin diseases reported so far. The scores for individual questions vary, but the degree of consistency of responses between questions is high. The differences between sexes, place of recruitment and grades of lymphoedema are not significant. Although the DLQI measures the quality of life due to lymphoedema, this study further warrants development of a good quality-of-life index for lymphoedema patients.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0035-9203</s0>
</fA01>
<fA02 i1="01"><s0>TRSTAZ</s0>
</fA02>
<fA03 i2="1"><s0>Trans. r. soc. trop. med. hyg.</s0>
</fA03>
<fA05><s2>100</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Use of the dermatology life quality index in filarial lymphoedema patients</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>BABU (B. V.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>NAYAK (A. N.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>RATH (K.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>KERKETTA (A. S.)</s1>
</fA11>
<fA14 i1="01"><s1>Division of Clinical and Epidemiology, Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1>
<s2>Bhubaneswar 751023</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>258-263</s1>
</fA20>
<fA21><s1>2006</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>3084</s2>
<s5>354000135338080100</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>31 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0124585</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Transactions of the Royal Society of Tropical Medicine and Hygiene</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The global programme to eliminate lymphatic filariasis has alleviation of suffering and disability as one of its components, and many efforts are being taken across the globe in this direction. However, there is no effective tool to assess the impact of these efforts on patients' quality of life and/or lessening of disability and suffering. The present paper reports the use of the Dermatology Life Quality Index (DLQI) in filarial lymphoedema patients. DLQI scores were collected from 203 patients recruited from a clinic and from the community. The DLQI score ranged from 0 to 17, and a mean score of 2.7 (SD 4.4) or 9.0% disability. This score is lower than many skin diseases reported so far. The scores for individual questions vary, but the degree of consistency of responses between questions is high. The differences between sexes, place of recruitment and grades of lymphoedema are not significant. Although the DLQI measures the quality of life due to lymphoedema, this study further warrants development of a good quality-of-life index for lymphoedema patients.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B12B04</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05E03B4D</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Filariose lymphatique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Lymphatic filariasis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Filariasis linfática</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Qualité vie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Quality of life</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Calidad vida</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Dermatologie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dermatology</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Dermatología</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Inde</s0>
<s2>NG</s2>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>India</s0>
<s2>NG</s2>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>India</s0>
<s2>NG</s2>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Médecine tropicale</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Tropical medicine</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Medicina tropical</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Nématodose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nematode disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Nematodosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Helminthiase</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Helminthiasis</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Helmintiasis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Parasitose</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Parasitosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Parasitosis</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Asie</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fN21><s1>072</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000417 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000417 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:06-0124585
   |texte=   Use of the dermatology life quality index in filarial lymphoedema patients
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Use of the dermatology life quality index in filarial lymphoedema patients

Use of the dermatology life quality index in filarial lymphoedema patients

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri